Interestingly, miR-34c was significantly reduced in striatum, in line with recent studies showing that miR-34 mitigates neurodegeneration (Liu et al., 2012), and inhibition of miR-34c enhances α-synuclein expression in PD (Kabaria et al., 2015). The gene discussed is SNCA; the disease is Parkinson disease.